Clinda-Tre
Broşür Referansları
Al-Qarqaz F et al. Post-acne hyperpigmentation: Evaluation of risk factors and the use of artificial neural network as a predictive classifier. Dermatology Reports. 2021; 13:8223
Fabbrocini et al. Evaluation, Prevention, and Management of Acne Scars: Issues, Strategies, and Enhanced Outcomes. Journal of Drugs in Dermatology. 2018; 17 (12): 44-50.
Fabbrocini et al. Evaluation, Prevention, and Management of Acne Scars: Issues, Strategies, and Enhanced Outcomes. Journal of Drugs in Dermatology. 2018; 17 (12): 44-50.
Callendar et al. Efficacy and Safety of Clindamycin Phosphate 1.2% and Tretinoin 0.025% Gel for the Treatment of Acne and Acne-induced Post-inflammatory Hyperpigmentation in Patients with Skin of Color. The Journalof Clinical and Aesthetic Dermatology. 2012; 5(7): 25-32.
Ochsendorf F. Clindamycin phosphate 1.2% / tretinoin 0.025%: A novel fixed-dose combination treatment for acne vulgaris. Journal of the European Academy of Dermatology and Venereology. 2015;29:8–13.
Conforti C et al. An overview of treatment options for mild‐to‐moderate acne based on American Academy of Dermatology, European Academy of Dermatology and Venereology, and Italian Society of Dermatology and venereology guidelines. Dermatologic Therapy. 2020;33(4).
